Cigna Corporation
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 174.07B | 180.52B | 195.26B | 247.12B | 274.95B | 11.3% | |
| Cost of Revenue | (151.12B) | (157.02B) | (170.09B) | (221.16B) | (248.97B) | 12.6% | |
Gross Profit | 22.95B | 23.50B | 25.18B | 25.96B | 25.99B | 0.1% | |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | |
| Selling, General & Administrative | (12.79B) | (13.04B) | (14.32B) | (14.57B) | (14.00B) | -3.9% | |
| Depreciation & Amortization | (1.80B) | (1.86B) | (1.81B) | (1.75B) | (2.63B) | 50.1% | |
Operating Income (EBIT) | 7.94B | 8.45B | 8.54B | 9.42B | 9.13B | -3.1% | |
| Non-Operating Items | |||||||
| Interest Income | — | — | — | — | — | — | |
| Interest Expense | (1.21B) | (1.23B) | (1.45B) | (1.44B) | (1.38B) | -3.8% | |
| Other Income/Expenses (Net) | -1.15B | -53.00M | -3.02B | -4.15B | -1.54B | -63.0% | |
Income Before Tax | 6.79B | 8.40B | 5.51B | 5.27B | 7.59B | 44.1% | |
| Income Tax Expense | (1.37B) | (1.61B) | (141.00M) | (1.49B) | (1.34B) | -9.8% | |
Net Income | 5.37B | 6.70B | 5.16B | 3.43B | 5.96B | 73.5% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $16 | $22 | $18 | $12 | $22 | 82.0% | |
| Weighted Avg Shares Outstanding | 337.96M | 313.06M | 296.88M | 280.29M | 265.95M | -5.1% | |
| Weighted Avg Shares Outstanding (Diluted) | 340.97M | 313.06M | 296.88M | 283.22M | 265.95M | -6.1% | |
EBITDA | 9.96B | 10.44B | 10.85B | 11.45B | 11.61B | 1.4% |
Explore CI
CI in the Healthcare
Large Cap